Cardiff Lexington Corp (CDIX) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Cardiff Lexington Corp (CDIX) stock forecast summary
Our AI ranks Cardiff Lexington Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for CDIX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.9% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CDIX included.
Follow CDIX freeCDIX price chart and AI forecast
How CDIX ranks among 5379 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cardiff Lexington Corp (CDIX) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Offices & Clinics of Doctors of Medicine peers listed below that report each metric.
Valuation & Market
| Metric | CDIX | Rank |
|---|---|---|
| EPS | $-1.05 | – |
Profitability & Margins
| Metric | CDIX | Rank |
|---|---|---|
| ROE | -561.3% | 6/6 |
| ROA | -32.1% | 7/8 |
| ROIC | -13.9% | 6/8 |
| Gross Margin | 61.0% | 5/6 |
| Operating Margin | -4.3% | 2/8 |
| Net Margin | -75.0% | 7/8 |
| EBT Margin | -42.5% | 7/8 |
Financial Health
| Metric | CDIX | Rank |
|---|---|---|
| Current Ratio | 0.91x | 4/8 |
| D/E Ratio | 15.44x | 1/6 |
| Financial Leverage | 17.48x | 1/6 |
| Interest Coverage | -109.8x | 7/8 |
| Working Capital | -$2M | 3/8 |
Cash Flow
| Metric | CDIX | Rank |
|---|---|---|
| Operating Cash Flow | -$3M | 7/8 |
Operational Efficiency
| Metric | CDIX | Rank |
|---|---|---|
| Payables Period | 108 days | 3/5 |
Income Statement
| Metric | CDIX | Rank |
|---|---|---|
| Operating Income | $0.00M | 2/8 |
| Net Income | -$9M | 5/8 |
| SG&A Expense | $7M | 6/7 |
| Cost of Goods Sold | $5M | 6/6 |
Dividend & Shareholder Information
| Metric | CDIX | Rank |
|---|---|---|
| EPS Growth | -1750.0% | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $24M | 79.2% of assets |
| Cash & Short-term Investments | $220K | 0.7% of assets |
| Accounts Receivable | $24M | 77.3% of assets |
| Total Liabilities | $27M | 88.3% of assets |
| Short-term Debt | $25M | 81.8% of assets |
CDIX quarterly financials and insider trading
Cardiff Lexington Corp (CDIX) industry peers
Companies classified under the same SEC industry code as Cardiff Lexington Corp (Services-Offices & Clinics of Doctors of Medicine): 8 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| CDIX Cardiff Lexington Corp | ▼ | N/A |
| TDOC Teladoc Health, Inc. | ▲ | $1.09B |
| SBC Sbc Medical Group Holdings Inc | ▼ | $547M |
| LFMD Lifemd, Inc. | ▲ | $119M |
| AIRS Airsculpt Technologies, Inc. | ▲ | $117M |
| HLYK Healthlynked Corp | ▶ | $7M |
| HIMS Hims & Hers Health, Inc. | ▲ | N/A |
| STLN Starling Oncology, Inc. | ▲ | N/A |
Where CDIX sits on the market map
Cardiff Lexington Corp (CDIX) stock news
Loading...
Cardiff Lexington Corp (CDIX) stock forecast FAQ
What is the Cardiff Lexington Corp (CDIX) stock forecast?
Our AI ranks Cardiff Lexington Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Cardiff Lexington Corp stock predictions?
A per-ticker accuracy statistic for CDIX is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cardiff Lexington Corp forecasts updated?
Cardiff Lexington Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Cardiff Lexington Corp's industry peers?
8 issuers in our coverage, CDIX included, share the SEC industry code Services-Offices & Clinics of Doctors of Medicine. The largest are: Teladoc Health, Inc. (TDOC), Sbc Medical Group Holdings Inc (SBC), Lifemd, Inc. (LFMD), Airsculpt Technologies, Inc. (AIRS), Healthlynked Corp (HLYK), Hims & Hers Health, Inc. (HIMS).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.